Failed rescue therapy with rapamycin after paraquat intoxication
- 5 November 2009
- journal article
- case report
- Published by Taylor & Francis Ltd in Clinical Toxicology
- Vol. 48 (1), 84-86
- https://doi.org/10.3109/15563650903376089
Abstract
Ingestion of large quantities of paraquat leads to irreversible, often fatal pulmonary fibrosis. Case presentation. A 50-year-old man (body weight of 78.6 kg) ingested 500 mL Gramoxone containing 200 g/L of paraquat in a suicide attempt. The patient did not seek medical attention until 15 h after ingestion. Initial treatment consisted of the administration of intravenous methylprednisolone, 250 mg once daily. Seventy-two hours after ingestion the patient was transferred to our tertiary care center. Paraquat concentration was 0.2 mg/L in the serum and urinary concentration was 4.42 mg/L. Antioxidative therapy including the administration of acetylcysteine and an anti-inflammatory therapy employing methylprednisolone (1 g/day) was started. Extended daily dialysis was initiated. As the high plasma concentration of paraquat indicated a 100% predicted mortality, we expanded treatment strategies by using the antiproliferative agent rapamycin. A dose of 8 mg/day was started 72 h after the intoxication. Maximum rapamycin concentrations amounted to 12.9 microg/L. Despite these efforts, the patient died on day 18 after intoxication from respiratory failure caused by severe pulmonary fibrosis. Despite theoretical considerations suggesting the use of rapamycin in paraquat poisoning, the substance failed to halt the progression of pulmonary fibrosis in this case.Keywords
This publication has 11 references indexed in Scilit:
- The clinical features of acute kidney injury in patients with acute paraquat intoxicationNephrology Dialysis Transplantation, 2008
- Use of sirolimus in a case of severe paraquat poisoningClinical Toxicology, 2008
- Randomized control trial of immunosuppression in paraquat poisoningCritical Care Medicine, 2007
- Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoningCritical Care Medicine, 2006
- SirolimusClinical Pharmacokinetics, 2005
- Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycleJournal of Cellular Physiology, 1993
- A NEW STATISTICAL APPROACH TO THE PROGNOSTIC SIGNIFICANCE OF PLASMA PARAQUAT CONCENTRATIONSThe Lancet, 1984
- Interstitial Pulmonary Fibrosis—Which Cell is the Culprit?1,2American Review of Respiratory Disease, 1983
- Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.The Journal of Antibiotics, 1975
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975